Galderma

Galderma is certainly the heavyweight for rosacea treatments and skincare. Rosacea sufferers will be familiar with Metrogel 1% and Oracea as well as their Cetaphil skincare range. More recently Galderma has gained approval for Mirvaso and also has CD5024/Ivermectin in development.

Recent Rosacea Blog Posts

Mysterious SPF 30 Sunscreen good for rosacea redness and dryness

A mysterious tinted sunscreen has been evaluated as part of a rosacea regime and been shown to be of benefit to rosacea sufferers. So what exactly is this tinted daily SPF30 sunscreen that warranted Galderma to sponsor publication in the Journal of Cosmetic Dermatology? The article doesn’t say, but some important clues can be found. […]

Continue Reading

Soolantra + Oracea faster together

Selling you two rosacea prescription rather than one. Sounds like the holy grail for someone with a portfolio of rosacea treatments. Of course `they’ are Galderma, and some recent publicity around a combination trial suggests that two may well be better than one. So, should you line up for two helpings of Galderma’s rosacea regime? […]

Continue Reading

Raising the bar on rosacea treatment – we want to be clear!

Galderma has created a major publicity campaign around the idea that the burden of suffering from rosacea is bigger than many doctors appreciate. The campaign seeks to create an expectation that all rosacea sufferers ought to reach a self declared `clear’ of their rosaea symptoms, promoting the idea that unless rosacea sufferers are able to […]

Continue Reading

Galderma for sale – why we need the right buyer

A for-sale sign is hanging outside the Galderma shop, shall we make them an offer? The rosacea behemoth that is Galderma could be about to change hands, read on to find out this sale could mean for rosacea sufferers and why we all have an interest in the new owner. Galderma was created in 1981 […]

Continue Reading

Generic Oracea – sadly just not going to happen

A recent ruling from a Delaware Federal judge has confirmed that Galderma’s patent protection covering Oracea is secure, and confirming that generic Oracea is just not going to happen. This most recent ruling found that Amneal Pharmaceuticals’s attempt to create a generic version of the once-daily low dose doxycycline treatment infringes 5 of Galderma’s US […]

Continue Reading

 

Top

Subscribe to Rosacea News

Enter your email address to receive the latest news about rosacea in your inbox.